Moscow Regional Research Clinical Institute. M.F. Vladimirsky
Moscow, 129110, Russia
NCT Number: NCT04215081
This study will evaluate the ExoAtlet II exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, to stand up and ambulate under a variety of conditions.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Moscow, 129110, Russia
The study will introduce the ExoAtlet II exoskeleton to SCI patients with lower extremity paralysis (partial or complete) and provide rehabilitative standing and walking intervention. The study will be conducted with a trained clinician that will fit each patient into the adjustable exoskeleton system and provide customized programming to meet each user's specific needs. The training program will be initiated based upon each patient's comfort in the exoskeleton and ability to stand with assistance. Each patient will be closely monitored to assess ongoing health as well as their individual standing and walking ability. All exoskeleton sessions will be performed with a trained medical professional controlling the exoskeleton. Patient safety is the primary concern and all adverse events will be documented and addressed. This study will evaluate the ExoAtlet 2.0 exoskeleton for safety and effectiveness of providing persons with a spinal cord injury (SCI) who are non-ambulatory or have limited ambulatory function, the ability to stand up and walk in a clinical facility.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Subjects will learn to use the ExoAtlet II exoskeleton, with the assistance of a trained medical professional, to perform functional activities (including stand-up, sit-down, stepping forward, and walking).
Time frame: 0-8 weeks
Document and track any adverse events, both minor and major, during exoskeleton sessions.
Time frame: 0-8 weeks
A visual inspection of the participant's skin, at all areas of contact with the exoskeleton, will be conducted at the beginning and end of each session.
Time frame: 1 Day
Assesses walking speed, in the exoskeleton, in meters per second over a distance of 10 meters
Time frame: 1 Day
Record the distance covered during a 6 minute walk test utilizing the exoskeleton, to evaluate users endurance
Time frame: 2 Days
Percentage of patients able to successfully transfer in and out of the exoskeleton with or without assistance
Time frame: 2 Days
Percentage of patients that successfully completed both sit to stand and stand to sit in the exoskeleton
COSMO ROBOTICS CO., Ltd
Industry
ExoAtlet II Lower Extremity Exoskeleton Safety and Efficacy Use With Spinal Cord Injured Individuals
Acronym: EXOATLET2SCI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04736849
Central Nervous System Diseases, Nervous System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT05432999
Central Nervous System Diseases, Muscle Hypertonia
West Orange, New Jersey, United States
View Trial DetailsNCT03495986
Behavior, Central Nervous System Diseases
Miami, Florida, United States
View Trial DetailsNCT05776862
Atrophy, Atrophy, Muscular
Miami, Florida, United States
View Trial Details